Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.40
+0.11000.97%
Post-market: 11.400.00000.00%19:30 EDT
Volume:218.90K
Turnover:2.48M
Market Cap:399.77M
PE:-95
High:11.47
Open:11.29
Low:10.88
Close:11.29
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.78M
Volume Ratio:1.16
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.42
PE(LYR):-33.44

Loading ...

Fennec grants 10,000 inducement stock options priced at $9 to new hire

Reuters
·
Jun 15

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 15

Fennec Pharmaceuticals highlights new ASCO studies on PEDMARK use to prevent cisplatin-induced hearing loss

Reuters
·
Jun 11

Fennec Pharmaceuticals held annual shareholder meeting, elected directors

Reuters
·
Jun 11

Fennec Announces Results of Annual Meeting

GlobeNewswire
·
Jun 11

Fennec Pharmaceuticals director Rosty Raykov disposes of common shares worth $93,790.14

Reuters
·
Jun 03

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Sutro Biopharma (STRO)

TIPRANKS
·
May 22

Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 22

Fennec price target raised to $16 from $13 at H.C. Wainwright

TIPRANKS
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Fennec says Phase 1 PEDMARK trial in metastatic germ cell tumors opens for accrual

Reuters
·
May 22

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

GlobeNewswire
·
May 22

Fennec grants 50,000 stock options to new hires at $9.75 per share

Reuters
·
May 19

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 19

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 19

Fennec Pharma publishes corporate presentation on PEDMARK hearing loss prevention in cisplatin patients

Reuters
·
May 19

Wedbush Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
May 18

Piper Sandler Sticks to Its Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
May 15

Fennec Q1 FY26 swings to profit of $201,000; net sales rise 72.64% to $15.11 million

Reuters
·
May 15

Fennec Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14